Clinical TrialsSearch results
Number of results: 521
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Tacrolimus as Second-line Therapy
- Autoimmune Hepatitis
- Chayama Kazuaki
- 2019-03-18
Other
- Randomized controlled trial of gemcitabine administration schedule in patients undergoing curative resection of biliary cancer
- Biliary cancer
- Biliary Cancer Treatment Group
- 2008-02-11
Recruiting
- The phase 2 study of neoadjuvant chemotherapy of GAS for biological borderline resectable pancreatic cancer.
- Biological borderline resectable pancreatic cancer
- Uemura Kenichiro
- 2018-12-07
Other
- neoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancer
- bladder cancer
- Department of Urology, Graduate School of Biomedical Sciences Hiroshima University
- 2010-02-08
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Not yet recruiting
- Clinical research on a neuroprotective effect of minocycline treatment in the acute stage of Ischemic Stroke
- Brain Infarction
- Takeshi Takahashi
- 2009-08-14
Other
- A phaseI/II study of TS-1 and Docetaxel with Metastatic Breast Cancer patients resisting for Docetaxel
- Breast Cancer
- Department of Breast and Thyroid Surgery, Kawasaki Medical School
- 2009-06-11
Other
- A randomized controlled study comparing Anastrozole+TS-1 as postoperative chemotherapy in ER positive metastatic breast cancer
- Breast Cancer
- Department of Breast and Thyroid Surgery, Kawasaki Medical School
- 2007-08-12
Other
- A Randomized Multicenter Phase2 Trial of Neoadjuvant Paclitaxel followed by Fluorouracil,Epirubin,and Cyclophosphamide(FEC)with or without Estrogen Deprivation by LH-RH agonist or Aromatase Inhibitor in Breast Cancer larger than 2 cm.
- Breast Cancer
- THE FIRST
- 2007-06-30
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06